In Brief: Roche European PCR patent:
This article was originally published in The Gray Sheet
Executive Summary
Roche European PCR patent: Hoffman-La Roche expects to receive a European patent within the next six months covering enzymes used in the company's polymerase chain reaction gene amplification technology. At a Nov. 6 hearing, the European Patent Office accepted Roche's claims for native and recombinant thermostable DNA polymerases, clearing the way for a patent covering "thermostable enzymes having DNA polymerase activity from any species of bacteria such as Taq DNA polymerase from Thermus aquaticus," the company says...